Reviewed,
UniProtKB/Swiss-Prot P14142 (GTR4_MOUSE)
Last modified
February 9, 2010.
Version 106.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Solute carrier family 2, facilitated glucose transporter member 4 Alternative name(s): Glucose transporter type 4, insulin-responsive Short name=GLUT-4 GT2 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus |
Protein attributes
| Sequence length | 509 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Insulin-regulated facilitative glucose transporter. |
| Subunit structure | Binds to DAXX. Interacts via its N-terminus with SRFBP1 By similarity. |
| Subcellular location | Endomembrane system; Multi-pass membrane protein By similarity. Cytoplasm › perinuclear region By similarity. Note: Localizes primarily to the perinuclear region, undergoing continued recycling to the plasma membrane where it is rapidly reinternalized. The dileucine internalization motif is critical for intracellular sequestration By similarity. |
| Tissue specificity | Skeletal and cardiac muscles; brown and white fat. |
| Involvement in disease | Defects in Slc2a4 may be the cause of certain post-receptor defects in non-insulin-dependent diabetes mellitus (NIDDM). |
| Miscellaneous | Insulin-stimulated phosphorylation of TBC1D4 is required for GLUT4 translocation. |
| Sequence similarities | Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. Glucose transporter subfamily. [View classification] |
Ontologies
| Keywords | |
|---|---|
| Biological process | Sugar transport Transport |
| Cellular component | Cytoplasm Membrane |
| Disease | Diabetes mellitus |
| Domain | Transmembrane |
| PTM | Glycoprotein Phosphoprotein |
| Gene Ontology (GO) | |
| Biological process | brown fat cell differentiation Inferred from direct assay. Source: MGI glucose transportInferred from direct assay. Source: MGI transmembrane transportInferred from electronic annotation. Source: InterPro |
| Cellular component | cytoplasmic vesicle membrane Inferred from direct assay. Source: MGI integral to membrane of membrane fractionInferred from direct assay. Source: MGI integral to plasma membraneInferred from direct assay. Source: MGI microsomeInferred from direct assay. Source: MGI perinuclear region of cytoplasmInferred from direct assay. Source: MGI trans-Golgi network transport vesicleInferred from direct assay. Source: MGI |
| Molecular function | insulin-responsive hydrogen:glucose symporter activity Traceable author statement. Source: MGI |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 509 | 509 | Solute carrier family 2, facilitated glucose transporter member 4 | PRO_0000050364 | |||||
Regions | |||||||||
| Topological domain | 1 – 23 | 23 | Cytoplasmic Potential | ||||||
| Transmembrane | 24 – 44 | 21 | 1 Potential | ||||||
| Topological domain | 45 – 80 | 36 | Extracellular Potential | ||||||
| Transmembrane | 81 – 101 | 21 | 2 Potential | ||||||
| Topological domain | 102 – 110 | 9 | Cytoplasmic Potential | ||||||
| Transmembrane | 111 – 131 | 21 | 3 Potential | ||||||
| Topological domain | 132 – 141 | 10 | Extracellular Potential | ||||||
| Transmembrane | 142 – 162 | 21 | 4 Potential | ||||||
| Topological domain | 163 – 170 | 8 | Cytoplasmic Potential | ||||||
| Transmembrane | 171 – 191 | 21 | 5 Potential | ||||||
| Topological domain | 192 – 200 | 9 | Extracellular Potential | ||||||
| Transmembrane | 201 – 221 | 21 | 6 Potential | ||||||
| Topological domain | 222 – 286 | 65 | Cytoplasmic Potential | ||||||
| Transmembrane | 287 – 307 | 21 | 7 Potential | ||||||
| Topological domain | 308 – 322 | 15 | Extracellular Potential | ||||||
| Transmembrane | 323 – 343 | 21 | 8 Potential | ||||||
| Topological domain | 344 – 352 | 9 | Cytoplasmic Potential | ||||||
| Transmembrane | 353 – 373 | 21 | 9 Potential | ||||||
| Topological domain | 374 – 384 | 11 | Extracellular Potential | ||||||
| Transmembrane | 385 – 405 | 21 | 10 Potential | ||||||
| Topological domain | 406 – 416 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 417 – 437 | 21 | 11 Potential | ||||||
| Topological domain | 438 – 444 | 7 | Extracellular Potential | ||||||
| Transmembrane | 445 – 465 | 21 | 12 Potential | ||||||
| Topological domain | 466 – 508 | 43 | Cytoplasmic Potential | ||||||
| Region | 7 – 13 | 7 | SRFBP1-binding By similarity | ||||||
| Region | 294 – 296 | 3 | Defines substrate specificity By similarity | ||||||
| Motif | 489 – 490 | 2 | Dileucine internalization motif Potential | ||||||
Amino acid modifications | |||||||||
| Modified residue | 488 | 1 | Phosphoserine Ref.5 | ||||||
| Glycosylation | 57 | 1 | N-linked (GlcNAc...) Ref.6 | ||||||
Experimental info | |||||||||
| Sequence conflict | 11 | 1 | D → DVK in AAA37753. Ref.1 | ||||||
| Sequence conflict | 132 | 1 | V → A in BAB03251. Ref.2 | ||||||
| Sequence conflict | 177 | 1 | Q → R in AAA37753. Ref.1 | ||||||
| Sequence conflict | 246 | 1 | R → P in AAA37753. Ref.1 | ||||||
| Sequence conflict | 406 | 1 | Missing in AAA37753. Ref.1 | ||||||
| Sequence conflict | 444 | 1 | A → R in AAA37753. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes." Kaestner K.H., Christy R.J., McLenithan J.C., Braiterman L.T., Cornelius P., Pekala P.H., Lane M.D. Proc. Natl. Acad. Sci. U.S.A. 86:3150-3154(1989) [PubMed: 2654938] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Age-dependent changes in phenotypes and candidate gene analysis in a polygenic animal model of type II diabetes; NSY mouse." Ueda H., Ikegami H., Kawaguchi Y., Fujisawa T., Nojima K., Babaya N., Yamada K., Shibata M., Yamato E., Ogihara T. Diabetologia 43:932-938(2000) [PubMed: 10952468] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Strain: C3H and NSY. Tissue: Muscle. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Colon. |
| [4] | "Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation." Sano H., Kane S., Sano E., Miinea C.P., Asara J.M., Lane W.S., Garner C.W., Lienhard G.E. J. Biol. Chem. 278:14599-14602(2003) [PubMed: 12637568] [Abstract] Cited for: EFFECT OF TBC1D4 ON GLUT4 TRANSLOCATION. |
| [5] | "Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry." Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J., Faessler R., Mann M. J. Proteome Res. 7:5314-5326(2008) [PubMed: 18973353] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, MASS SPECTROMETRY. |
| [6] | "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins." Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D. Nat. Biotechnol. 27:378-386(2009) [PubMed: 19349973] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-57, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | M23383 mRNA. Translation: AAA37753.1. AB008453 mRNA. Translation: BAB03251.1. BC014282 mRNA. Translation: AAH14282.1. |
| IPI | IPI00762242. |
| PIR | B30310. |
| RefSeq | NP_033230.2. |
| UniGene | Mm.10661 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | P14142. |
PTM databases | |
| PhosphoSite | P14142. |
Proteomic databases | |
| PRIDE | P14142. |
Genome annotation databases | |
| Ensembl | ENSMUST00000018710; ENSMUSP00000018710; ENSMUSG00000018566; Mus musculus. [Genome view] |
| GeneID | 20528. |
| KEGG | mmu:20528. |
Organism-specific databases | |
| CTD | 20528. |
| MGI | MGI:95758. Slc2a4. |
Phylogenomic databases | |
| eggNOG | roNOG11437. |
| HOGENOM | HBG744444. |
| HOVERGEN | P14142. |
| InParanoid | P14142. |
| PhylomeDB | P14142. |
Gene expression databases | |
| ArrayExpress | P14142. |
| Bgee | P14142. |
| Genevestigator | P14142. |
| GermOnline | ENSMUSG00000018566. Mus musculus. |
Family and domain databases | |
| InterPro | IPR002441. Glc_transpt_4. IPR016196. MFS_general_subst_transpt. IPR003663. Sugar/inositol_transpt. IPR005829. Sugar_transporter_CS. [Graphical view] |
| PRINTS | PR01193. GLUCTRSPORT4. PR00171. SUGRTRNSPORT. |
| TIGRFAMs | TIGR00879. SP. 1 hit. |
| PROSITE | PS50850. MFS. 1 hit. PS00216. SUGAR_TRANSPORT_1. 1 hit. PS00217. SUGAR_TRANSPORT_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| SOURCE | Search... |
Entry information
| Entry name | GTR4_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P14142 Secondary accession number(s): Q9JJN9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


